Initial information regarding this unsolicited case was received from United States on 11-Dec-2015 from a 
consumer.
This case involved two patients, both with unknown demographic details, who passed away, unspecified time 
duration after receiving treatment with alirocumab (Praluent).
No past drugs, medical history, concurrent conditions and concomitant medications were reported.
On an unknown date, both the patients commenced the therapy with alirocumab (dose, form, route, frequency, lot 
number and expiry date: unknown) for an unknown indication. 
It was reported that on an unknown date, after unspecified time duration, both the patients passed away while on 
alirocumab from the same doctor's clinic. It was unknown whether the autopsy was done or not, however the cause
Print Time: 12-JAN-2016 04:52 PM If a field is blank, there is no data for that field Page 33 of 35
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
of death was also reported as unknown.
Outcome: Fatal.
Seriousness criteria:  Both the patients died.